Zhejiang Haisen Pharmaceutical Co., Ltd.

¥18.98As of Sun 8 Nov 2026, 12:00 UTC
SZSE:001367Healthcare
Country China
PE (Fwd) •••
TSR 4Y CAGR (8.13%)
Div yield 0.61%
ROE 9.86%
Drug Manufacturers (General)
Beta (5Y) 0.25
PE TTM 19.58
TSR TTM (20.14%)
Mkt cap ¥2.853B
ROIC 30.27%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥22
18.08%
(25.14%)
Hold 3|7|6|8|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.25
0.27
0.28
0.31
1.73%
5.83%
6.93%
21.70%
Revenue¥M
155.4
164.3
162.9
161.6
4.24%
9.44%
7.77%
2.46%
Peers (US$427.7M)
Cap (US$)
PE
482.5M
381.2x
326.9M
189.3x
Capital
TTM
5Y
10Y
Leveragex
1.016
0.122
0.117
EBIT/Intx
0.425
0.574
0.493
Own earn%
(239.73)
(164.35)
(143.08)
Sh yield%
24.12
29.44
29.73
Owners
Insiders/Inst%
0.44
56.71
Short interest%
3.71
SBC / revenue%
0.52
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
18–27
$1 testx
—
Incr. ROIC%
6